Polycystic ovarian syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: ProGsterol 3 grams sachet includes 30 mg Deglusterol, VIRA RAHESH Pharmed Pharmaceutical Co, Once a day, 45-60 minutes before breakfast. Intervention 2: Control gro
Sponsors
VIRA RAHESH PHARMED Pharmaceutical Co
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women with Poly Cystic Ovary Syndrome confirmed based on the Rotterdam criteria candidate for IVF
Exclusion criteria
Exclusion criteria: Endometrioma Uterus Myoma Women that their husband needs TESE or PESA Type 1 or 2 Diabetes Mellitus Inflammatory disease or Autoimmune disease Acute cardiovascular disease Liver disease Kidney disease Cancer Central hypogonadism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of oocytes. Timepoint: Before the intervention and 1 month after intervention. Method of measurement: Counting by microscope.;Embryo quality. Timepoint: 3 months after intervention. Method of measurement: Microscope.;Rate of Pregnancy. Timepoint: 4 months after intervention. Method of measurement: Counting. | — |
Secondary
| Measure | Time frame |
|---|---|
| Waist Hip Ratio. Timepoint: Before the intervention and 4 months after intervention. Method of measurement: Size assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRobabeh Taheripanah
Shahid Beheshti University of Medical Sciences
Outcome results
None listed